Cem Gorgun in

Cem Gorgun

Energizer · DISC type I
Director, Oncology Clinical Development at BioNTech SE
📍 Cambridge, Massachusetts, United States

Cem Gorgun is a physician-scientist and oncology development leader with over 15 years of experience in the biopharmaceutical industry. As a Director at BioNTech, he focuses on immuno-oncology, bispecifics, and first-in-human clinical programs. He completed his post-doctoral fellowship at Harvards T. H. Chan School of Public Health.

Outside of his direct professional responsibilities, he has contributed to philanthropic causes. He is listed as a donor to the Turkish Philanthropy Funds, an organization dedicated to creating lasting change by supporting communities in Turkey and the US.

He has recently co-authored multiple publications on investigational bispecific antibody immunotherapies, including Acasunlimab, for treating metastatic non-small cell lung cancer.

Read the full overview →
Experience
21 Years
Current Role
Director, Oncology Clinical Development
Job Level
Mid-senior
Location
Cambridge, Massachusetts, United States
Personality Overview

How Cem shows up

Big Picture Person
Imaginative
Believer

They are not always early adopters but can be pursuaded by leveraging strong relationships. They are really good at seeing what the long-term impacts of their decisions could be. They are always positive and upbeat, so take their promises with a pinch of salt.

Priorities

Topics Cem cares about

Immuno-Oncology
A core area of his expertise, reflected in his current role at BioNTech and numerous recent publications on bispecific antibodies and immunotherapies.
Bispecific Antibodies
His work and publications, such as those on Acasunlimab and BNT314, show a deep focus on developing and testing bispecific antibody platforms for cancer treatment.
+5 more topics Login to view topics
Career

Work history

7-2023
Director, Oncology Clinical Development
BioNTech SE
7-2023
Global Clinical Lead
BioNTech SE
6-2021 - 7-2023
Medical Director, Oncology Clinical Science
Takeda Oncology
7-2020 - 6-2021
Scientific Director, Oncology Global Medical Affairs
Takeda Oncology
11-2017 - 7-2020
Assoc. Scientific Director Oncology Pipeline, Global Medical Affairs,
Takeda Oncology
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2000 - 2004
Post Doctoral Fellow
Harvard T.H. Chan School of Public Health
1993 - 1998
PhD Equil
Department of Medical Pharmacology, School of Medicine, Gazi University
Social presence
in
Behavioral profile

DISC profile (public)

I

Influence (I)

Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.

Other BioNTech SE Employees

Explore more public profiles from related professionals.

Lorraine S.
Lorraine S.
Vice President US Marketing and Sales
BioNTech SE
 Mac Connor
Mac Connor
US Marketing
BioNTech SE
 Gary M. Bufferd, Q-IAOCR
Gary M. Bufferd, Q-IAOCR
Director, Training Management - Global Clinical Development Operations (BioNTech US)
BioNTech SE
 Dr. Viktoria Klara Wandt
Dr. Viktoria Klara Wandt
Associate Director Internal Training & Development GMA
BioNTech SE

More profiles

Discover additional public profiles from our index.

Derek Spencer
Derek Spencer
Senior Product Manager
Illumina
 Miquel Lladó Tugas
Miquel Lladó Tugas
Chief Executive Officer
MAGserveis
 David Robillard
David Robillard
Advisory Board Member
Valital
 Amy Guterman
Amy Guterman
Senior Director, AI for Impact
Salesforce
Unlock the full playbookSee exactly how to sell to Cem. Free, 10 seconds.